• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

POCl3 氯化 4-喹唑酮。

POCl3 chlorination of 4-quinazolones.

机构信息

AstraZeneca, Pharmaceutical Development, Silk Road Business Park, Charter Way, Macclesfield, Cheshire SK10 2NA, UK.

出版信息

J Org Chem. 2011 Mar 18;76(6):1653-61. doi: 10.1021/jo102262k. Epub 2011 Feb 4.

DOI:10.1021/jo102262k
PMID:21294532
Abstract

The reaction of quinazolones with POCl(3) to form the corresponding chloroquinazolines occurs in two distinct stages, which can be separated through appropriate temperature control. An initial phosphorylation reaction occurs readily under basic conditions (R(3)N, aq pK(a) > 9) at t < 25 °C to give a variety of phosphorylated intermediates. Pseudodimer formation, arising from reaction between phosphorylated intermediates and unreacted quinazolone, is completely suppressed at these temperatures, provided the system remains basic throughout the POCl(3)addition. Clean turnover of phosphorylated quinazolones to the corresponding chloroquinazoline is then achieved by heating to 70-90 °C. (N)- and (O)-phosphorylated intermediates, involving multiple substitution at phosphorus, have been identified and their reactions monitored using a combination of (1)H, (31)P, and (19)F NMR. Kinetic analysis of the reaction profiles suggest that the various intermediates react with both Cl(-) and Cl(2)P(O)O(-), but product formation arises exclusively from reaction of (O)-phosphorylated intermediates with Cl(-). (O)- and (N)-phosphorylated intermediates equilibrate rapidly on the time scale of the reaction. A minimum of 1 molar equiv of POCl(3) is required for efficient conversion of the intermediates to product.

摘要

喹唑啉与 POCl(3)的反应分为两个不同的阶段,通过适当的温度控制可以将它们分离。在碱性条件下(R(3)N,aq pK(a) > 9),温度低于 25°C 时,很容易发生初始的磷酸化反应,生成各种磷酸化中间体。在这些温度下,只要体系在整个 POCl(3)添加过程中保持碱性,磷酸化中间体和未反应的喹唑啉之间的假二聚体形成就会完全被抑制。通过加热至 70-90°C,可以实现磷酸化喹唑啉向相应的氯喹唑啉的清洁转化。已经鉴定出涉及磷上多取代的 (N)-和 (O)-磷酸化中间体,并使用 (1)H、(31)P 和 (19)F NMR 对其反应进行了监测。反应曲线的动力学分析表明,各种中间体与 Cl(-)和 Cl(2)P(O)O(-)都反应,但产物的形成仅来自于 (O)-磷酸化中间体与 Cl(-)的反应。(O)-和 (N)-磷酸化中间体在反应时间尺度上迅速达到平衡。至少需要 1 摩尔当量的 POCl(3)才能有效地将中间体转化为产物。

相似文献

1
POCl3 chlorination of 4-quinazolones.POCl3 氯化 4-喹唑酮。
J Org Chem. 2011 Mar 18;76(6):1653-61. doi: 10.1021/jo102262k. Epub 2011 Feb 4.
2
Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activation.有机磷合成中的主要中间体(三氯化磷、三氯氧磷、三氯硫磷及其二乙酯)直接或经活化后都是抗胆碱酯酶剂。
Chem Res Toxicol. 2003 Mar;16(3):350-6. doi: 10.1021/tx020094l.
3
[Synthesis of hetero-condensed quinazolones: 1,2,4-triazino[6,1-b]- and 1,2,5-triazino[2,3-b]quinazolones].[杂环稠合喹唑啉酮的合成:1,2,4-三嗪并[6,1-b]-和1,2,5-三嗪并[2,3-b]喹唑啉酮]
Acta Pharm Hung. 1997 Nov;67(6):255-61.
4
Electron attachment to POCl3. III. Measurement and kinetic modeling of branching fractions.三价磷酰氯(POCl3)的电子俘获。III. 分支比的测量和动力学建模。
J Chem Phys. 2011 Mar 7;134(9):094310. doi: 10.1063/1.3549139.
5
Diverse modes of reactivity of dialkyl azodicarboxylates with P(III) compounds: synthesis, structure, and reactivity of products other than the Morrison-Brunn-Huisgen intermediate in a Mitsunobu-type reaction.偶氮二甲酸二烷基酯与P(III)化合物的多种反应模式:在光延反应类型中除莫里森-布伦-惠斯根中间体之外的产物的合成、结构及反应活性
J Org Chem. 2004 Mar 19;69(6):1880-9. doi: 10.1021/jo035634d.
6
[Synthesis of potential CCK antagonist quinazolone derivatives. II].[潜在的胆囊收缩素拮抗剂喹唑啉衍生物的合成。II]
Acta Pharm Hung. 1995 Sep;65(5):175-81.
7
The time-dependent distribution of phosphorylated intermediates in native sarcoplasmic reticulum Ca2+-ATPase from skeletal muscle is not compatible with a linear kinetic model.来自骨骼肌的天然肌浆网Ca2+-ATP酶中磷酸化中间体的时间依赖性分布与线性动力学模型不相符。
Biochemistry. 2004 Apr 13;43(14):4400-16. doi: 10.1021/bi035068g.
8
Fragmentation of oxygen-containing molecules via C-O bond cleavage promoted by coordination to niobium and tantalum pentahalides.通过与五卤化铌和钽配位促进的C-O键断裂实现含氧化合物分子的碎片化。
Dalton Trans. 2009 Sep 14(34):6759-72. doi: 10.1039/b905023j. Epub 2009 Jul 20.
9
Further characterization of Mitsunobu-type intermediates in the reaction of dialkyl azodicarboxylates with P(III) compounds.偶氮二甲酸二烷基酯与P(III)化合物反应中 Mitsunobu 型中间体的进一步表征
J Org Chem. 2006 Feb 3;71(3):1002-8. doi: 10.1021/jo051997x.
10
Detailed spectroscopic, thermodynamic, and kinetic studies on the protolytic equilibria of Fe(III)cydta and the activation of hydrogen peroxide.关于Fe(III)cydta的质子解离平衡以及过氧化氢活化的详细光谱、热力学和动力学研究。
Inorg Chem. 2009 Aug 17;48(16):7864-84. doi: 10.1021/ic900834z.

引用本文的文献

1
Development and Optimization of a Novel Synthetic Route for 2,4-Diamine-quinazoline Containing Ziresovir: A Drug Candidate for the Treatment of Respiratory Syncytial Virus (RSV) Infection.含齐瑞索韦的2,4-二氨基喹唑啉新型合成路线的开发与优化:一种治疗呼吸道合胞病毒(RSV)感染的候选药物。
ACS Omega. 2025 Aug 13;10(33):38175-38181. doi: 10.1021/acsomega.5c06080. eCollection 2025 Aug 26.
2
A Brand-New Metal Complex Catalyst-Free Approach to the Synthesis of 2,8-Dimethylimidazo[1,2-]pyridazine-6-Carboxylic Acid-A Key Intermediate in Risdiplam Manufacturing Process.一种全新的无金属配合物催化剂方法用于合成2,8-二甲基咪唑并[1,2 -]哒嗪-6-羧酸——利司扑兰生产过程中的关键中间体。
Molecules. 2025 Jul 18;30(14):3011. doi: 10.3390/molecules30143011.
3
Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: Design, Synthesis, Radiolabeling, Biodistribution, and Molecular Modeling Simulation.基于氰基吡啶酮和氰基吡啶的癌细胞Pim-1抑制剂:设计、合成、放射性标记、生物分布及分子模拟。
ACS Omega. 2023 May 24;8(22):19351-19366. doi: 10.1021/acsomega.2c08304. eCollection 2023 Jun 6.
4
Design, synthesis, and biological evaluation of new thieno[2,3-] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study.新型噻吩并[2,3-d]嘧啶衍生物的设计、合成及作为 PI3K 靶向治疗的生物评价及其分子模拟研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):315-332. doi: 10.1080/14756366.2021.2010729.
5
Design, Synthesis and Biological Evaluation of 7-Chloro-9-pyrimido[4,5-]indole-based Glycogen Synthase Kinase-3β Inhibitors.7-氯-9-嘧啶并[4,5-]吲哚基糖原合酶激酶-3β抑制剂的设计、合成与生物评价。
Molecules. 2019 Jun 25;24(12):2331. doi: 10.3390/molecules24122331.
6
Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives.一些新型4-苯胺基喹唑啉衍生物的对接研究、合成及抗菌活性评价
Res Pharm Sci. 2017 Oct;12(5):425-433. doi: 10.4103/1735-5362.213988.
7
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.3-羟基嘧啶-2,4-二酮-5-N-苄基羧酰胺可有效抑制HIV-1整合酶和核糖核酸酶H。
J Med Chem. 2016 Jul 14;59(13):6136-48. doi: 10.1021/acs.jmedchem.6b00040. Epub 2016 Jun 17.
8
Synthesis and photophysical property studies of the 2,6,8-triaryl-4-(phenylethynyl)quinazolines.2,6,8-三芳基-4-(苯乙炔基)喹唑啉的合成及光物理性质研究。
Molecules. 2014 Jan 10;19(1):795-818. doi: 10.3390/molecules19010795.